Data / Drug companies / Calcium acetate
Calcium acetate: 20 companies and 22 products in the FDA NDC directory
Calcium acetate is listed in the FDA National Drug Code Directory by 20 companies, with 22 products in commercial distribution. 22 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; tablet, and the newest product started marketing on July 5, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 20
- Products
- 22
- Generic (ANDA) products
- 22 (100.0%)
- Application numbers
- 10
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list calcium acetate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Chartwell RX, LLC | 2 | capsule; tablet | Generic drugs (ANDA) | July 1, 2019 |
| Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc. | 2 | tablet; capsule | Generic drugs (ANDA) | July 7, 2015 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | July 5, 2026 |
| American Health Packaging | 1 | capsule | Generic drugs (ANDA) | July 18, 2013 |
| Amneal Pharmaceuticals of New York LLC | 1 | capsule | Generic drugs (ANDA) | October 8, 2014 |
| AvKARE | 1 | capsule | Generic drugs (ANDA) | May 21, 2025 |
| AvPAK | 1 | capsule | Generic drugs (ANDA) | May 28, 2026 |
| Cardinal Health 107, LLC | 1 | capsule | Generic drugs (ANDA) | February 26, 2008 |
| Cipla USA Inc. | 1 | capsule | Generic drugs (ANDA) | July 26, 2016 |
| Exelan Pharmaceuticals Inc. | 1 | capsule | Generic drugs (ANDA) | April 14, 2014 |
| Hikma Pharmaceuticals USA Inc. | 1 | capsule | Generic drugs (ANDA) | February 26, 2008 |
| Major Pharmaceuticals | 1 | capsule | Generic drugs (ANDA) | February 26, 2008 |
| NCS HealthCare of Ky, LLC DBA Vangard Labs | 1 | capsule | Generic drugs (ANDA) | December 7, 2023 |
| Nivagen Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | December 7, 2023 |
| PD-Rx Pharmaceuticals, Inc. | 1 | capsule | Generic drugs (ANDA) | December 7, 2023 |
| Proficient Rx LP | 1 | capsule | Generic drugs (ANDA) | June 13, 2025 |
| Remedyrepack Inc. | 1 | capsule | Generic drugs (ANDA) | March 2, 2025 |
| Rising Pharma Holdings, Inc. | 1 | capsule | Generic drugs (ANDA) | November 1, 2021 |
| Square Pharmaceuticals Limited | 1 | capsule | Generic drugs (ANDA) | May 31, 2023 |
| Westminster Pharmaceuticals, LLC | 1 | capsule | Generic drugs (ANDA) | June 13, 2025 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule | 20 | 90.9% |
| Tablet | 2 | 9.1% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Blood Coagulation Factor | 22 |
| Phosphate Binder | 20 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.